Articles for
December 2005 |
|
Select Month |
|
|
Brazil Could Turn a Trade Victory Into Defeat -
MARY ANASTASIA O'GRADY
Mary Anastasia O'Grady writes of Brazil's tactics at the WTO and its history on TRIPS and AIDS drug prices, quoting the AFM and AEI paper on Brazil's AIDS treatment program. |
|
ASTMH Presentations on DDT -
Download the presentations made by Richard Tren & Katy French at the recent ASTMH session on DDT and IRS |
|
Carson's bridge to malaria -
Dimitri Vassilaros
Allegheny bridge has been renamed to honour Rachel Carson - author of "Silent Spring". This move is both unfortunate and inappropriate. Millions of people, mainly women and children, die each year beacuse of the junk science surrounding DDT. |
|
Bukenya pleads for DDT use -
Vision Reporter
Vice-President Prof. Gilbert Bukenya has appealed to the international community to support Uganda’s fight to eradicate malaria, including the use of DDT against mosquitoes.
|
|
Stop the Rachel Carson Bridge -
Junk Science Action Alert!
The Allegheny County Council (Pennsylvania) will meet today (Dec. 6) to rename its Ninth Street Bridge in honor of Silent Spring author Rachel Carson whose junk science-fueled crusade against DDT has helped condemn tens of millions of the world's poor to death and sickness from malaria. Given the fact that millions of people in developing countries have died from malaria as a result of Carson's junk science on DDT, we think this move would be outrageous and unacceptable.
|
|
Tackling Malaria the DDT Way -
Dr. Matthias Offoboche
Dr. Matthias Offoboche, a former Deputy Governor of the old Cross Rivers State calls for Nigeria to start IRS with DDT in order to tackle malaria. |
|
Doctors warn of misusing malaria drug -
Jessica Berman
Scientists are concerned that a new and effective anti-malaria drug has started to show signs of resistance in Africa. They are concerned about the misuse of the drug, artemisinin and what that could mean for the treatment of malaria. |
|
Africa must engage directly in fight against malaria -
Wen Kilama
Until an effective vaccine is developed to prevent malaria, countries should adopt a well-managed IRS program using DDT. It has proven to be the most effective and least costly intervention available – it has the potential to save countless lives and prevent millions of unnecessary bouts of illness. |
|
A Vital Weapon Against HIV/Aids -
C. Payne Lucas
The worldwide destruction brought on by HIV/Aids cannot be overcome by an after-the-fact crisis management approach. We need a war mindset. The pandemic calls for a multi-pronged attack, especially in Africa, where the havoc has been most disastrous and threatens to undo 50 years of hard-won progress in public health, education, and development .... |
|
Anti-malaria mutations 'cancel each other out'
Two genetic mutations that, individually, can protect people from malaria, cancel each others' protective effect if they are inherited together, say scientists.
They say their findings, published online yesterday (16 October) by Nature Genetics, could help researchers better understand how genes make some people immune to malaria, and why one of the mutations is not widespread in sub-Saharan Africa.
The two mutations are best known for causing the genetic disorders alpha-thalassaemia and sickle-cell disease. Both alter haemoglobin, the protein in red blood cells that carries oxygen around the body.
Although it is well known that the mutations give people a degree of protection against malaria, the mechanisms behind this are poorly understood.
Moreover, researchers know little about whether this protective effect remains when both mutations are inherited together.
Thomas Williams, of the Kenya Medical Research Institute, and colleagues decided to investigate this effect in children from Kenya's Kilifi district.
The team found that children with just one of the mutations had fewer cases of severe malaria than children with neither mutation. But children carrying both mutations had no protection from the disease.
The team showed that children with the sickle-cell mutation had fewer parasites in their blood. But this effect was not seen in children with both mutations.
The other alpha-thalassaemia mutation is prevalent in several populations in Oceania and South Asia, but much less common in sub-Saharan Africa.
The researchers suggest that the presence of the sickle-cell mutation in sub-Saharan Africa, and its cancelling effect on the protection against malaria given by alpha-thalassaemia, could be preventing the latter disease from taking root in the region.
Reference: Nature Genetics 309, 1088 (2005)
SciDev.Net
|